The E2F transcription factor is a cellular target for the RB protein

Although it is generally believed that the product of the retinoblastoma susceptibility gene (RB1) is an important regulator of cell proliferation, the biochemical mechanism for its action is unclear. We now show that the RB protein is found in a complex with the E2F transcription factor and that only the under phosphorylated form of RB is in the E2F complex. Moreover, the adenovirus E1A protein can dissociate the E2F-RB complex, dependent on E1A sequence also critical for E1A to bind to RB. These sequences are also critical for E1A to immortalize primary cell cultures and to transform in conjunction with other oncogenes. Taken together, these results suggest that the interaction of RB with E2F is an important event in the control of cellular proliferation and that the dissociation of the complex is part of the mechanism by which E1A inactivates RB function.

[1]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[2]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[3]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[4]  J. Yokota,et al.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. , 1988, Oncogene.

[5]  Tony Hunter,et al.  Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 , 1989, Cell.

[6]  M. Mathews,et al.  Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1. , 1990, The Journal of biological chemistry.

[7]  P. Branton,et al.  Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. , 1985, Virology.

[8]  R. Weinberg,et al.  Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.

[9]  R. Weichselbaum,et al.  Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Nevins,et al.  Activation of the E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product , 1990, Journal of virology.

[11]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[12]  J. Nevins,et al.  Selective induction of human heat shock gene transcription by the adenovirus E1A gene products, including the 12S E1A product , 1987, Molecular and cellular biology.

[13]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Maller,et al.  Purified maturation promoting factor phosphorylates pp60c-src at the sites phosphorylated during fibroblast mitosis , 1989, Cell.

[15]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[16]  J. Nevins,et al.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A , 1991, Cell.

[17]  S. Friend,et al.  Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein , 1990, Journal of virology.

[18]  P. Yaciuk,et al.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity , 1990, Journal of virology.

[19]  P. Robbins,et al.  Negative regulation of human c-fos expression by thes retinoblastoma gene product , 1990, Nature.

[20]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[21]  J. Nevins,et al.  Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. , 1991, Genes & development.

[22]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[23]  W. Benedict,et al.  The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. , 1989, Oncogene.

[24]  J. Nevins,et al.  An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Shenk,et al.  An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. , 1989, Genes & development.

[26]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[27]  E. Y. Lee,et al.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product , 1991, Nature.

[28]  S. Friend,et al.  Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Varley,et al.  Structural rearrangement of the retinoblastoma gene in human breast carcinoma. , 1988, Science.

[30]  B R Franza,et al.  Association of adenovirus early-region 1A proteins with cellular polypeptides , 1986, Molecular and cellular biology.

[31]  R. Weinberg,et al.  Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Sporn,et al.  Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Yen,et al.  Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. , 1989, Science.

[34]  L. Hood,et al.  Identification of cellular proteins binding to the scrapie prion protein. , 1990, Biochemistry.

[35]  Chun-Ming Huang,et al.  SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family , 1989, Cell.

[36]  W. J. Brammar,et al.  The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. , 1989, Oncogene.

[37]  J. Azizkhan,et al.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo , 1989, Molecular and cellular biology.

[38]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[39]  Jonathan A. Cooper,et al.  RB and the cell cycle: Entrance or exit? , 1989, Cell.

[40]  E. Harlow,et al.  Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.

[41]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[42]  P. Yaciuk,et al.  TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.

[43]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[44]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[45]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[46]  J. Nevins,et al.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding , 1989, Molecular and cellular biology.

[47]  M. Loeken,et al.  The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection. , 1989, The Journal of biological chemistry.

[48]  P. Branton,et al.  Binding of the Rb1 protein to E1A products is required for adenovirus transformation. , 1989, Oncogene.

[49]  R. Roberts,et al.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products , 1987, Molecular and cellular biology.

[50]  J. Nevins,et al.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation , 1990, Cell.

[51]  J. Nevins,et al.  Identification of a cellular transcription factor involved in E1A trans-activation , 1986, Cell.

[52]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Hearing,et al.  Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection , 1989, Journal of virology.